What is the EMA guideline on computerised systems?
- User
What is the EMA guideline on computerised systems?
- Assistant
The European Medicines Agency (EMA) has published a guideline on good manufacturing practice (GMP) specific to computerized systems used in the manufacture of medicinal products for human and veterinary use. The guideline, titled "Guideline on Good Manufacturing Practice for Computerized Systems in Regulation (EU) 2017/745 and Regulation (EU) 2017/746" (EMA/CVMP/GMP/2018/06), provides recommendations on the design, implementation, operation, and maintenance of computerized systems used in the manufacture of medicinal products.
The guideline covers various aspects of computerized systems, including:
- Validation: The guideline recommends that computerized systems should be validated to ensure that they are fit for their intended use and that they consistently produce accurate and reliable results. This includes the use of a risk-based approach to determine the extent and depth of validation required.
- Security: The guideline emphasizes the importance of ensuring the security and integrity of computerized systems, including access controls, data backup and recovery, and network security.
- Change management: The guideline recommends that changes to computerized systems should be controlled and documented, and that the impact of any changes on product quality should be assessed.
- System lifecycle: The guideline recommends that computerized systems should be managed throughout their lifecycle, from initial design and implementation to decommissioning.
- Documentation: The guideline recommends that documentation related to computerized systems should be kept up-to-date and that it should be possible to trace the history of any changes made to the system.
The EMA guideline on computerized systems is intended to help manufacturers ensure that they are complying with GMP requirements when using computerized systems in the manufacture of medicinal products. It is applicable to both human and veterinary medicines, and it applies to all computerized systems used in the manufacture of medicinal products, including those used for data acquisition, processing, and reporting.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.